Eden Research plc Exercise of Options (2991N)

TIDMEDEN

RNS Number : 2991N

Eden Research plc

08 May 2018

8 May 2018

Eden Research plc

("Eden" or "Company")

Exercise of Options

Director/PDMR Shareholding

Eden Research plc (AIM: EDEN), the AIM listed company that provides breakthrough natural microencapsulation technologies to the global agrochemicals, animal health and consumer products industries, announces it has issued 125,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") following the exercise of 125,000 options at 10.4 pence per share by the Company's Chief Financial Officer, Alex Abrey, under the Company's share option scheme.

Application has been made for the new Ordinary Shares to be admitted to trading on AIM, which is expected to take place on 14 May 2018. The new Ordinary Shares will rank, pari passu, with the existing Ordinary Shares in issue.

Following the transaction outlined above Mr Abrey's interest in the share capital of the Company has increased to a total of 1,163,160 Ordinary Shares representing 0.56 per cent. of the Company's issued share capital enlarged pursuant to the exercise of options.

Total Voting Rights

Following the issue of the new Ordinary Shares, the Company will have 207,189,337 ordinary shares of 1 pence each in issue. No Ordinary Shares are held in treasury. The figure of 207,189,337 may be used by the Company's shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further details of the PDMR dealings set out above.

 
 1      Details of the person discharging managerial responsibilities / person closely associated 
 a)     Name                                                     Mr Alex Abrey 
       -------------------------------------------------------  ------------------------------------------------------ 
 2      Reason for the notification 
       --------------------------------------------------------------------------------------------------------------- 
 a)     Position/status                                          Chief Financial Officer 
       -------------------------------------------------------  ------------------------------------------------------ 
 b)     Initial notification /Amendment                          Initial notification 
       -------------------------------------------------------  ------------------------------------------------------ 
 3      Details of the issuer, emission allowance market participant, auction platform, auctioneer 
         or auction monitor 
       --------------------------------------------------------------------------------------------------------------- 
 a)     Name                                                     Eden Research plc 
       -------------------------------------------------------  ------------------------------------------------------ 
 b)     LEI                                                      213800ZWTYTVQQSM3J85 
       -------------------------------------------------------  ------------------------------------------------------ 
 4      Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
         each type of transaction; (iii) each date; and (iv) each place where transactions have been 
         conducted 
       --------------------------------------------------------------------------------------------------------------- 
 a)     Description of the financial instrument, type of         Ordinary shares of 1 pence each in the Company 
        instrument                                               ("Ordinary Shares") 
 
        Identification code                                      GB0001646941 
       -------------------------------------------------------  ------------------------------------------------------ 
 b)     Nature of the transaction                                Exercise of Options over Ordinary Shares 
       -------------------------------------------------------  ------------------------------------------------------ 
 
                                                                    Exercise Price(s)   Volume(s) 
 
   c)     Price(s) and volume(s)                                     10.4 pence per      125,000 Ordinary 
                                                                     share               Shares 
                                                                                       ------------------ 
       -------------------------------------------------------  ------------------------------------------------------ 
 d)     Aggregated information 
 
         - Aggregated volume 
                                                                   N/A (single transaction) 
         - Price 
       -------------------------------------------------------  ------------------------------------------------------ 
 e)     Date of the transaction                                  07/05/2018 
       -------------------------------------------------------  ------------------------------------------------------ 
 f)     Place of the transaction                                 Outside of a trading venue. 
       -------------------------------------------------------  ------------------------------------------------------ 
 

For further information contact:

 
 Eden Research plc                  www.edenresearch.com 
 Sean Smith 
  Alex Abrey                        01285 359 555 
 
 Shore Capital (Nomad)              020 7408 4090 
 Stephane Auton / Patrick Castle 
 
 Powerscourt (Financial PR)         020 7250 1446 
 Nick Dibden 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCGUGDUCDGBGII

(END) Dow Jones Newswires

May 08, 2018 02:00 ET (06:00 GMT)